Biogen Inc
NASDAQ: BIIB
$141.06
-$2.60 (-1.8%)
Real Time Data Delayed 15 Min.
BIIB Articles
Biogen may be on track to be one of the first companies with a meaningful treatment for Alzheimer’s disease, and this could have huge implications for the stock.
Published:
The June 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Monday's top analyst upgrades and downgrades included American Express, Biogen, Discover Financial, DraftKings, Ericsson, Foot Locker, Gap, Kraft Heinz, Nikola, Walmart and Zscaler.
Published:
Canaccord Genuity recently released a report detailing some of the biggest biotech catalysts coming out over these next six months.
Published:
The May 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Tuesday's top analyst upgrades and downgrades included Avaya, Biogen, Broadcom, Chevron, Domino's Pizza, eBay, MGIC Investment, RealReal, Sprout Social, T-Mobile, Zoom Video Communications and Zynga.
Published:
Last Updated:
The May 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks was mixed.
Published:
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
The April 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Thursday's top analyst upgrades and downgrades included Apple, AT&T, Avis Budget, Baidu, Baker Hughes, Biogen, Chipotle Mexican Grill, Kinder Morgan, Netflix, Shopify and Ulta Beauty.
Published:
Biogen reported better than expected first-quarter financial results before the markets opened on Wednesday.
Published:
24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports due this week, including Amazon, Tesla, Netflix and Starbucks.
Published:
The March 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks shrank.
Published:
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.